Founded in 1989, Integra LifeSciences is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard products and solutions is trusted by healthcare professionals to improve patient outcomes. Our comprehensive neurosurgery portfolio spans dural access and repair, cerebrospinal fluid management, and neuro-critical and surgical care. In tissue reconstruction, our technologies support treatment for burns and deep tissue wounds, repair of dura mater in the brain, nerve and tendon repair, and acute and chronic wound management, as well as plastic and reconstructive surgery. Through strategic acquisitions and focused R&D, we’ve expanded into surgical instruments, neurosurgical and ear, nose and throat technologies, and advanced wound care—enabling clinicians to transform care. Today, Integra LifeSciences operates globally with more than 4,400 employees and offices, manufacturing sites, and research facilities across the Americas, Europe Asia-Pacific and the Middle East. Our leading brands —including Acclarent®, Codman®, CUSA®, DuraGen®, DuraSeal®, DuraSorb®, Integra®, PriMatrix®, SurgiMend®, and many others reflect our commitment to innovating for outcomes and enriching life moments.